Samsung Electronics is set to unveil a beta version of its AI Health Coach through the Samsung Health app in the US, marking ...

Amarna Therapeutics and NorthX Biologics finalized an agreement to advance Nimvec AM510 gene therapy toward clinical trials for Type 1 Diabetes. Now in its fourth year, the MM+M Media Summit brings ...

Welcome to Computing's weekly roundup of tech news in Asia. This time we look at the attempted extradition by the US of an ...

Sanofi buys a drug from Dren Bio to claim a stake in the emerging field of deep B-cell depletion for autoimmune diseases.

Novartis says Fabhalta shows sustained efficacy in rare disease C3G over 12 months, as it prepares for an FDA filing later this year.